E. Jeffrey North

MedicineBiochemistry, Genetics and Molecular BiologyPharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “MmpL3 Inhibition: A New Approach to Treat Nontuberculous Mycobacterial Infections”.

MmpL3 Inhibition: A New Approach to Treat Nontuberculous Mycobacterial Infections

International Journal of Molecular Sciences(2020)10.3390/ijms21176202

N/A

0DataRank · unranked

33 citations

Melanie Sowards, Mary Jackson, E. Jeffrey North, Jigar P. Sethiya

Structural Determinants of Indole-2-carboxamides: Identification of Lead Acetamides with Pan Antimycobacterial Activity

Journal of Medicinal Chemistry(2022)10.1021/acs.jmedchem.2c00352

N/A

0DataRank · unranked

14 citations

Pooja Hegde, Wei Li, Pavan Kumar Prathipati, Casey M. Stevens, Lixinhao Yang +14 more

Recent advances in mycobacterial membrane protein large 3 inhibitor drug design for mycobacterial infections

Expert Opinion on Drug Discovery(2023)10.1080/17460441.2023.2218082

N/A

0DataRank · unranked

31 citations

Chris Schwartz, Helen I. Zgurskaya, Mary Jackson, E. Jeffrey North

Pre-formulation development of highly potent nontuberculous mycobacterial agents

Results in Chemistry(2025)10.1016/j.rechem.2025.102307

N/A

0DataRank · unranked

0 citations

E. Jeffrey North, Alekha K. Dash, Satish G. Agrawal